These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32205176)

  • 41. Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
    Chen CF; Hsu EC; Lin KT; Tu PH; Chang HW; Lin CH; Chen YJ; Gu DL; Lin CH; Wu JY; Chen YT; Hsu MT; Jou YS
    Hepatology; 2010 Nov; 52(5):1690-701. PubMed ID: 20799341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
    Kaur H; Bhalla S; Raghava GPS
    PLoS One; 2019; 14(9):e0221476. PubMed ID: 31490960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ChARM: Discovery of combinatorial chromatin modification patterns in hepatitis B virus X-transformed mouse liver cancer using association rule mining.
    Park SH; Lee SM; Kim YJ; Kim S
    BMC Bioinformatics; 2016 Dec; 17(Suppl 16):452. PubMed ID: 28105934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular pathological approach to cancer epigenomics and its clinical application.
    Kanai Y
    Pathol Int; 2024 Apr; 74(4):167-186. PubMed ID: 38482965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
    Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY
    Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
    Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
    Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma.
    Zhang ZZ; Huang J; Wang YP; Cai B; Han ZG
    Int J Cancer; 2015 Aug; 137(4):765-75. PubMed ID: 25612832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interplay of genetic and epigenetic alterations in hepatocellular carcinoma.
    Lee SM; Kim-Ha J; Choi WY; Lee J; Kim D; Lee J; Choi E; Kim YJ
    Epigenomics; 2016 Jul; 8(7):993-1005. PubMed ID: 27411963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma.
    Subat S; Mogushi K; Yasen M; Kohda T; Ishikawa Y; Tanaka H
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):675-684. PubMed ID: 30564899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification.
    Li CW; Chiu YK; Chen BS
    Dis Markers; 2018; 2018():8635329. PubMed ID: 30344796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.
    Umeda S; Kanda M; Kodera Y
    Expert Rev Mol Diagn; 2019 Aug; 19(8):725-738. PubMed ID: 31248309
    [No Abstract]   [Full Text] [Related]  

  • 60. Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.
    Liao H; Liao M; Xu L; Yan X; Ren B; Zhu Z; Yuan K; Zeng Y
    EBioMedicine; 2019 Mar; 41():310-319. PubMed ID: 30665854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.